公司资料
BioLife Solutions 股价、新闻与催化剂
- 股票代码:
- BLFS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
36.78 USD (-5.33%)
收盘价
最后更新: 2026年10月1日
1.34B USD
市值
股价为何变动
截至 2026年10月1日，BLFS 下跌 5.33%，收于 $36.78。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Cell and Gene Therapy Tools Supplier
BioLife Solutions develops and supplies cell-processing tools used by biotechnology companies, clinical programs, and commercial manufacturers across the cell and gene therapy market.
Biopreservation Media
CryoStor and HypoThermosol media are designed to preserve cells and tissues during freezing, storage, shipping, and clinical handling. These products are incorporated into a large number of clinical trials and approved cell and gene therapies.
Cell-Processing Consumables
The portfolio includes CellSeal cryogenic vials, human platelet lysate products, and other materials used in cell manufacturing. These products support closed or controlled workflows as therapies move from research into regulated production.
Embedded Clinical-to-Commercial Model
Once a BioLife product is written into a therapy's manufacturing process, changing suppliers can require technical and regulatory work. This creates recurring demand as customer programs advance from clinical trials to commercial treatment volumes.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。